{"organizations": [], "uuid": "a6af0546c6c120d3513a16f68ae5c48ab34e15cc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-genkyotex-fy-consolidated-net-loss/brief-genkyotex-fy-consolidated-net-loss-of-25773-thousand-euros-idUSFWN1QI1FL", "country": "US", "domain_rank": 408, "title": "BRIEF-Genkyotex FY Consolidated Net Loss of 25,773 thousand euros", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.531, "site_type": "news", "published": "2018-03-01T01:01:00.000+02:00", "replies_count": 0, "uuid": "a6af0546c6c120d3513a16f68ae5c48ab34e15cc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-genkyotex-fy-consolidated-net-loss/brief-genkyotex-fy-consolidated-net-loss-of-25773-thousand-euros-idUSFWN1QI1FL", "ord_in_thread": 0, "title": "BRIEF-Genkyotex FY Consolidated Net Loss of 25,773 thousand euros", "locations": [], "entities": {"persons": [{"name": "genkyotex", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - GENKYOTEX SA:\n* GENKYOTEX‘S CASH RUNWAY EXTENDS THROUGH Q1 2019\n* ‍GENKYOTEX RECORDED FY CONSOLIDATED NET LOSS OF -EUR 25,773 THOUSAND​\n* TWO PHASE II CLINICAL TRIALS ONGOING FOR GKT831 * INTERIM ANALYSIS RESULTS IN PRIMARY BILIARY CHOLANGITIS EXPECTED IN FIRST HALF OF 2018\n* ‍FY RECURRING OPERATING LOSS INCLUDES A SHARE-BASED PAYMENTS EXPENSE OF EUR 3,838 THOUSAND​\n* ‍ON DECEMBER 31, 2017, GENKYOTEX HAD CASH, CASH EQUIVALENTS AND SHORT-TERM PLACEMENTS OF EUR 14.6 MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-01T01:01:00.000+02:00", "crawled": "2018-03-01T21:13:03.013+02:00", "highlightTitle": ""}